Recent Finacing
Recent Raise
Tavros Therapeutics operates a bi-directional synthetic lethality platform combining functional and computational genomics to identify paired genetic tumor vulnerabilities, prioritize biomarker-driven drug targets, and advance small-molecule candidates.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
